711 related articles for article (PubMed ID: 18929127)
21. Endocannabinoids as emerging suppressors of angiogenesis and tumor invasion (review).
Bifulco M; Laezza C; Gazzerro P; Pentimalli F
Oncol Rep; 2007 Apr; 17(4):813-6. PubMed ID: 17342320
[TBL] [Abstract][Full Text] [Related]
22. Molecular and cell-based approaches for neuroprotection in glaucoma.
Lebrun-Julien F; Di Polo A
Optom Vis Sci; 2008 Jun; 85(6):417-24. PubMed ID: 18521011
[TBL] [Abstract][Full Text] [Related]
23. The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma.
Harada T; Harada C; Nakamura K; Quah HM; Okumura A; Namekata K; Saeki T; Aihara M; Yoshida H; Mitani A; Tanaka K
J Clin Invest; 2007 Jul; 117(7):1763-70. PubMed ID: 17607354
[TBL] [Abstract][Full Text] [Related]
24. Future possibilities in glaucoma therapy.
Wierzbowska J; Robaszkiewicz J; Figurska M; Stankiewicz A
Med Sci Monit; 2010 Nov; 16(11):RA252-9. PubMed ID: 20980972
[TBL] [Abstract][Full Text] [Related]
25. Cannabinoid receptors in atherosclerosis.
Steffens S; Mach F
Curr Opin Lipidol; 2006 Oct; 17(5):519-26. PubMed ID: 16960500
[TBL] [Abstract][Full Text] [Related]
26. Current and emerging medical therapies in the treatment of glaucoma.
Bagnis A; Papadia M; Scotto R; Traverso CE
Expert Opin Emerg Drugs; 2011 Jun; 16(2):293-307. PubMed ID: 21406029
[TBL] [Abstract][Full Text] [Related]
27. The ocular effects of cannabinoids.
Green K
Curr Top Eye Res; 1979; 1():175-215. PubMed ID: 233656
[No Abstract] [Full Text] [Related]
28. Adenine nucleotides and dinucleotides as new substances for the treatment of ocular hypertension and glaucoma.
Pintor J
Curr Opin Investig Drugs; 2005 Jan; 6(1):76-80. PubMed ID: 15675606
[TBL] [Abstract][Full Text] [Related]
29. The role of endothelin in the pathophysiology of glaucoma.
Good TJ; Kahook MY
Expert Opin Ther Targets; 2010 Jun; 14(6):647-54. PubMed ID: 20455789
[TBL] [Abstract][Full Text] [Related]
30. Combined effect of brain-derived neurotrophic factor and LINGO-1 fusion protein on long-term survival of retinal ganglion cells in chronic glaucoma.
Fu QL; Li X; Yip HK; Shao Z; Wu W; Mi S; So KF
Neuroscience; 2009 Aug; 162(2):375-82. PubMed ID: 19422885
[TBL] [Abstract][Full Text] [Related]
31. [The modulatory role of endocannabinoids in sleep].
Murillo-Rodríguez E
Rev Neurol; 2008 Feb 1-15; 46(3):160-6. PubMed ID: 18297624
[TBL] [Abstract][Full Text] [Related]
32. Endocannabinoids in pain modulation.
Walker JM; Huang SM
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):235-42. PubMed ID: 12052039
[TBL] [Abstract][Full Text] [Related]
33. Neuroprotection in the treatment of glaucoma--A focus on connexin43 gap junction channel blockers.
Chen YS; Green CR; Danesh-Meyer HV; Rupenthal ID
Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):182-93. PubMed ID: 25676338
[TBL] [Abstract][Full Text] [Related]
34. Soft cannabinoid analogues as potential anti-glaucoma agents.
Buchwald A; Derendorf H; Ji F; Nagaraja NY; Wu WM; Bodor N
Pharmazie; 2002 Feb; 57(2):108-14. PubMed ID: 11878185
[TBL] [Abstract][Full Text] [Related]
35. Cannabinoids and atherosclerosis.
Fisar Z
Prague Med Rep; 2009; 110(1):5-12. PubMed ID: 19591373
[TBL] [Abstract][Full Text] [Related]
36. Rational basis for the development of coenzyme Q10 as a neurotherapeutic agent for retinal protection.
Russo R; Cavaliere F; Rombolà L; Gliozzi M; Cerulli A; Nucci C; Fazzi E; Bagetta G; Corasaniti MT; Morrone LA
Prog Brain Res; 2008; 173():575-82. PubMed ID: 18929135
[TBL] [Abstract][Full Text] [Related]
37. History of neuroprotection and rationale as a therapy for glaucoma.
Levin LA; Peeples P
Am J Manag Care; 2008 Feb; 14(1 Suppl):S11-4. PubMed ID: 18284310
[TBL] [Abstract][Full Text] [Related]
38. Use of cannabinoid derivatives in glaucoma.
Newell FW; Jay WM; Sternberg P
Trans Ophthalmol Soc U K (1962); 1979 Jul; 99(2):269-71. PubMed ID: 298426
[No Abstract] [Full Text] [Related]
39. Therapeutic potentials of aspirin in glaucomatous optic neuropathy.
Attarzadeh A; Hosseini H; Nowroozizadeh S
Med Hypotheses; 2006; 67(2):375-7. PubMed ID: 16527427
[TBL] [Abstract][Full Text] [Related]
40. [Retinal ganglion cells death in glaucoma--mechanism and potential treatment. Part II].
Rokicki W; Dorecka M; Romaniuk W
Klin Oczna; 2007; 109(7-9):353-5. PubMed ID: 18260297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
